Daytrana

Narcolepsy, Attention Deficit Hyperactivity Disorder

Treatment

20 Active Studies for Daytrana

What is Daytrana

Methylphenidate

The Generic name of this drug

Treatment Summary

Methylphenidate (Ritalin, Concerta, Biphentin) is a medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD), a condition with symptoms such as inattentiveness, hyperactivity, and impulsivity. It works by increasing the levels of certain chemicals in the brain that help improve focus and attention. Methylphenidate is available in long-acting and short-acting forms and is usually taken once a day. However, it has a high potential for abuse and dependence due to its effects on dopamine levels in the brain, so it should be used with caution. Non-stim

Methylphenidate Hydrochloride

is the brand name

image of different drug pills on a surface

Daytrana Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Methylphenidate Hydrochloride

Methylphenidate

1955

490

Effectiveness

How Daytrana Affects Patients

Methylphenidate is a mixture of two types of molecules. One type is more effective than the other at targeting areas of the brain, like the prefrontal cortex, that are related to Attention Deficit Hyperactivity Disorder (ADHD). In some animal studies, this drug has been seen to increase movement and cause repetitive behaviors.

How Daytrana works in the body

Methylphenidate helps manage ADHD symptoms by increasing the amount of dopamine and norepinephrine in the brain. It works differently at different doses. Low doses improve brain function and reduce movement, impulsivity, and inattention. Higher doses have the opposite effect and can impair cognition and cause increased movement. Methylphenidate may also reduce symptoms by targeting a gene abnormality that is linked to ADHD.

When to interrupt dosage

The proposed measure of Daytrana is dependent upon the diagnosed affliction. The amount of dosage changes based on the mode of administration featured in the table below.

Condition

Dosage

Administration

Attention Deficit Hyperactivity Disorder

20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Capsule, Capsule - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, chewable, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release - Oral, Suspension, extended release, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral

Narcolepsy

20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Capsule, Capsule - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, chewable, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release - Oral, Suspension, extended release, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral

Warnings

Daytrana Contraindications

Condition

Risk Level

Notes

advanced arteriosclerosis

Do Not Combine

Gilles de la Tourette syndrome

Do Not Combine

Thyrotoxicosis

Do Not Combine

Pulse Frequency

Do Not Combine

Open-angle glaucoma

Do Not Combine

Hypertensive disease

Do Not Combine

Pulse Frequency

Do Not Combine

Tension-Type Headache

Do Not Combine

Generalized Anxiety Disorder

Do Not Combine

symptomatic cardiovascular disease

Do Not Combine

Tourette Syndrome

Do Not Combine

Pheochromocytoma

Do Not Combine

Tics

Do Not Combine

Agitation

Do Not Combine

There are 20 known major drug interactions with Daytrana.

Common Daytrana Drug Interactions

Drug Name

Risk Level

Description

Desflurane

Major

Methylphenidate may increase the hypertensive activities of Desflurane.

Diethyl ether

Major

Methylphenidate may increase the hypertensive activities of Diethyl ether.

Enflurane

Major

Methylphenidate may increase the hypertensive activities of Enflurane.

Halothane

Major

Methylphenidate may increase the hypertensive activities of Halothane.

Isoflurane

Major

Methylphenidate may increase the hypertensive activities of Isoflurane.

Daytrana Toxicity & Overdose Risk

Overdosing on Phentermine may cause vomiting, restlessness, shaking, overactive reflexes, muscle spasms, seizures, feeling of euphoria, disorientation, hallucinations, delirium, sweating, blushing, headache, high fever, fast heart rate, abnormal heart rhythms, high blood pressure, enlarged pupils, and dryness of the mouth. The lowest toxic dose in mice is 190 mg/kg when taken orally.

image of a doctor in a lab doing drug, clinical research

Daytrana Novel Uses: Which Conditions Have a Clinical Trial Featuring Daytrana?

84 active trials are currently being conducted to evaluate the potential of Daytrana in treating Attention Deficit Hyperactivity Disorder.

Condition

Clinical Trials

Trial Phases

Attention Deficit Hyperactivity Disorder

61 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2

Narcolepsy

2 Actively Recruiting

Not Applicable, Phase 1

Daytrana Reviews: What are patients saying about Daytrana?

5

Patient Review

4/3/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

This was the medication that finally helped me after being diagnosed with ADHD in my late 30s. I've tried other oral options before, but this one made the most noticeable difference to both myself and those around me.

5

Patient Review

8/29/2020

Daytrana for Attention Deficit Disorder with Hyperactivity

This medication has been a life-changing miracle for me. I've been on it for two years and am now living a productive, organized, and happy life. Other stimulants couldn't even compare to this one in my opinion.

4.7

Patient Review

8/16/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

I was diagnosed with ADD at 55. It kept me from losing my professional career due to consistent poor work evaluations with carrying out instructions as a manager..

4

Patient Review

8/18/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

Overall, this did a great job. The only downside is that it can be irritating to your skin the first time you use it.

4

Patient Review

9/6/2013

Daytrana for Attention Deficit Disorder with Hyperactivity

My grandson uses this patch and it has really helped him. He was afraid of bugs, wouldn't eat, and always wanted to be by his dad's side. Now he is much more relaxed and doesn't have restless legs anymore.

4

Patient Review

5/22/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

I've seen a dramatic change in my 14 year old son since he started this treatment. He's much more focused at school and puts forth a lot more effort now.

3.7

Patient Review

4/16/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

The patch is very difficult to get the backing off. I did find that if I applied an ice cube to the back (the part you peel off) at the point you are supposed to pull, it pops up much easier. Up till I figured that out, I was wasting 1 out of 3. I just run the cube over one point for a moment, then bend it so it popps up, then kinda fold it so it doesn't restick. Then to the other side and repeat the process. Other than this and a bit of a red welt after usage, it is better than pills.

2.3

Patient Review

2/8/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

I don't like transdermal patches. They make my skin red if I forget to take them off on time, and it's a pain to have to shave my legs all the time.

1.7

Patient Review

1/23/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

This medication was recommended to me when I was diagnosed with ADHD six years ago. Unfortunately, it did not help at all. If anything, it made my symptoms worse and turned me into a completely different person. I'm glad I was eventually taken off the medication and taught how to manage my ADHD without medicine.

1

Patient Review

8/12/2014

Daytrana for Attention Deficit Disorder with Hyperactivity

My son developed homicidal tendencies after only two days of taking this drug. He grabbed his best friend by the throat and restricted his air flow just because he wouldn't take a bracelet off of my sons arm fast enough.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about daytrana

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Daytrana get you high?

"Like any other stimulant, there is a potential for addiction when using Daytrana. Methylphenidate, the active ingredient in Daytrana, can produce a feeling of euphoria when taken in high doses, stimulating the brain's pleasure and reward system."

Answered by AI

What are the side effects of Daytrana?

"The following are potential side effects that may occur: feeling nervous, trouble sleeping, loss of appetite, weight loss, dizziness, nausea, vomiting, or headache. Additionally, the affected area may become mildly irritated or red. If any of these side effects persist or worsen, you should notify your doctor or pharmacist."

Answered by AI

Is Daytrana the same as Adderall?

"Is Daytrana the same medication as Adderall? Daytrana (methylphenidate) and Adderall (amphetamine and dextroamphetamine salts) are both central nervous system stimulants that are used to treat attention deficit hyperactivity disorder (ADHD), with Adderall also being used to treat narcolepsy."

Answered by AI

Is Daytrana and Ritalin the same?

"TheDaytrana patchis a new way to deliver the medication methylphenidate, which is also available in tablet forms such as Ritalin and Concerta. The patch offers a new and unique delivery system for this medication."

Answered by AI

Clinical Trials for Daytrana

Image of Seattle Children's Hospital in Seattle, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Seattle, WA

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Seattle Children's Hospital

Image of St. Jude Children's Research Hospital in Memphis, United States.

Methylphenidate for Sickle Cell Disease

8 - 17
All Sexes
Memphis, TN

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to help with any thinking, attention or schoolwork problems and if they have any side effects. The study will assess any thinking or attention problems participants may have both before taking this drug and after. Additionally, the study will assess the decision-making process of the caregiver that may influence using this drug or not. Primary Objective: • Assess the feasibility, acceptability, and adherence to MPH treatment in children with SCD and EF deficits. Secondary Objective: • Evaluate neurobehavioral and safety outcomes following MPH treatment. Exploratory Objective: • Evaluate decision-making and determinants influencing methylphenidate utilization among parents.

Phase 1
Recruiting

St. Jude Children's Research Hospital

Andrew Heitzer, PhD

Have you considered Daytrana clinical trials?

We made a collection of clinical trials featuring Daytrana, we think they might fit your search criteria.
Go to Trials
Image of The University of Iowa in Iowa City, United States.

fMRI for Cognitive Flexibility

18 - 35
All Sexes
Iowa City, IA

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Waitlist Available
Has No Placebo

The University of Iowa

Image of UCSF Nancy Friend Pritzker Psychiatry Building in San Francisco, United States.

Trigeminal Nerve Stimulation for ADHD in Children with Autism

7 - 14
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Recruiting
Device

UCSF Nancy Friend Pritzker Psychiatry Building

Image of The University of Texas at Austin in Austin, United States.

Transcranial Photobiomodulation for ADHD

18 - 44
All Sexes
Austin, TX

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Waitlist Available
Online Trial

The University of Texas at Austin

Have you considered Daytrana clinical trials?

We made a collection of clinical trials featuring Daytrana, we think they might fit your search criteria.
Go to Trials
Image of Louisiana State University in Baton Rouge, United States.

Virtual Reality for ADHD

18 - 25
All Sexes
Baton Rouge, LA

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.

Phase 4
Waitlist Available

Louisiana State University (+1 Sites)

Joshua M Langberg, PhD

Image of Duke University in Durham, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Durham, NC

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Duke University

John Mitchell, PhD

Image of Kennedy Krieger Institute in Baltimore, United States.

Iron Supplementation for ADHD and Restless Sleep

8 - 18
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn if iron supplementation works to restless sleep in youth with ADHD. A second goal is to learn if iron supplementation helps to ease ADHD symptoms. The main questions that this trial aims to answer are: Does 3 months of iron supplementation treatment improve parent- and youth self-reported sleep difficulties more than placebo? Does 3 months of iron supplementation treatment improve sleep as measured by actigraphy more than placebo? Does 3 months of iron supplementation treatment improve parent-reported and/or objectively measured attention more than placebo? Researchers will compare over-the-counter iron supplementation treatment to a placebo (a look-alike substance that contains no drug) to see if iron supplementation works to treat sleep difficulties in youth with ADHD. Participants will: * Take iron supplements every day for 3 months * Visit the clinic once before treatment begins and once at the end of treatment to complete tests and rating scales related to sleep and attention * Wear motion-monitoring leg bands while sleeping for one 2-week period before treatment begins and one 2-week period at the end of treatment

Phase 1 & 2
Waitlist Available

Kennedy Krieger Institute

Alison E Pritchard, PhD

Image of Montana State University in Bozeman, United States.

Speech-Gesture Combinations for Autism

Any Age
All Sexes
Bozeman, MT

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minimally verbal individuals with Autism Spectrum Disorders (ASD), who are especially disadvantaged by the lack of accessible services in their rural communities. Individuals with other cognitive profiles, including Developmental Language Disorder (DLD), ADHD, Dyslexia, and others are welcome too. The study uses methods of eye tracking and recording of brain activity to understand how hand gestures adapted from signs from American Sign Language, such as \[cry\], can promote successful understanding of words like "cry". The overarching goal is to help families effectively utilize gestures to support communication with their children.

Recruiting
Has No Placebo

Montana State University

Have you considered Daytrana clinical trials?

We made a collection of clinical trials featuring Daytrana, we think they might fit your search criteria.
Go to Trials